If product liability lawsuits are brought against us; we may incur substantial liabilities and may be required to limit commercialization of our product candidates. We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical studies; and will face an even greater risk if we sell our product candidates commercially. An individual may bring a liability claim against us if one of our product candidates causes; or merely appears to 50 Table of Contents Index to Financial Statements have caused; an injury. If we cannot successfully defend ourselves against product liability claims; we will incur substantial liabilities. Regardless of merit or eventual outcome; liability claims may result in the following decreased demand for our product candidates impairment to our business reputation withdrawal of clinical study participants distraction of management s attention from our primary business substantial monetary awards to patients or other claimants the inability to commercialize our product candidates and loss of revenues. We do carry product liability insurance for our clinical studies. Further; we intend to expand our insurance coverage to include the sale of commercial products if marketing approval is obtained for any of our product candidates. However; we may be unable to obtain this product liability insurance on commercially reasonable terms and with insurance coverage that will be adequate to satisfy any liability that may arise. On occasion; large judgments have been awarded in class action or individual lawsuits relating to marketed pharmaceuticals. A successful product liability claim or series of claims brought against us could cause our stock price to decline and; if judgments exceed our insurance coverage; could decrease our cash and adversely affect our business.